[go: up one dir, main page]

PE20000231A1 - Metodo para tratar copd (enfermedad pulmonar obstructiva cronica) - Google Patents

Metodo para tratar copd (enfermedad pulmonar obstructiva cronica)

Info

Publication number
PE20000231A1
PE20000231A1 PE1999000011A PE00001199A PE20000231A1 PE 20000231 A1 PE20000231 A1 PE 20000231A1 PE 1999000011 A PE1999000011 A PE 1999000011A PE 00001199 A PE00001199 A PE 00001199A PE 20000231 A1 PE20000231 A1 PE 20000231A1
Authority
PE
Peru
Prior art keywords
cr4r5
alkyl
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
PE1999000011A
Other languages
English (en)
Inventor
Iv Siegfried B Christensen
Theodore Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE20000231A1 publication Critical patent/PE20000231A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Indole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE AL USO DEL COMPUESTO I, R1 ES -(CR4R5)nCOO(CR4R5)mR6, -(CR4R5)nCONR4(CR4R5)mR6, ENTRE OTROS; m ES 0-2; n ES 1-4; R4 Y R5 SON H, ALQUILO C1-C2; R6 ES H, METILO, OH, ENTRE OTROS, CUANDO R6 ES OH, m ES 2; CUANDO R6 ES 2-TETRAHIDROPIRANILO, 2-TETRAHIDROTIOPIRANILO, ENTRE OTROS, m ES 1-2; CUANDO n ES 1, m ES 0; R6 NO ES H EN -(CR4R5)nO(CR4R5)mR6; X ES YR2, HALO, NITRO, ENTRE OTROS; Y ES O, S(O)m`; m' ES 0-2; X2 ES O, NR8; X3 ES H o X; X4 ES UN GRUPO a, b; X5 ES H, R9, OR8, ENTRE OTROS; R2 ES -CH3, -CH2CH3; s ES 0-4; R3 ES H, HALO, ALQUILO C1-C4, ENTRE OTROS; Z ES CY'R14, CY'NR10R14, ENTRE OTROS; Y' ES O o S; R7 ES -(CR4R5)qR12, ALQUILO C1-C6; q ES 0-2; R12 ES CICLOALQUILO C3-C7, 2-PIRIDILO, ENTRE OTROS; R8 ES H, R9; R9 ES ALQUILO C1-C4; R10 ES OR8 o R11; R11 ES H, ALQUILO C1-C4; R13 ES OXAZOLIDINILO, OXAZOLILO, ENTRE OTROS; R14 ES H o R7; CUANDO R10 Y R14 SON NR10R14, JUNTO CON N FORMAN UN ANILLO DE 5 A 7 MIEMBROS, CUANDO R12 ES N-PIRAZOLILO, N-IMIDAZOLILO, ENTRE OTROS; q NO ES 1. UN COMPUESTO PREFERIDO ES CIS-[ACIDO 4-CIANO-4-(3-CICLOPENTILOXI-4-METOXIFENIL)CICLOHEXANO-1-CARBOXILICO], ENTRE OTROS. EL COMPUESTO I INHIBE LA QUIMIOTAXIS Y LA DESGRANULACION DE NEUTROFILOS Y PUEDE SER UTIL PARA EL TRATAMIENTO DE LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA (COPD)
PE1999000011A 1998-01-07 1999-01-06 Metodo para tratar copd (enfermedad pulmonar obstructiva cronica) PE20000231A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7071898P 1998-01-07 1998-01-07
US10690898P 1998-10-28 1998-10-28

Publications (1)

Publication Number Publication Date
PE20000231A1 true PE20000231A1 (es) 2000-03-24

Family

ID=26751429

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000011A PE20000231A1 (es) 1998-01-07 1999-01-06 Metodo para tratar copd (enfermedad pulmonar obstructiva cronica)

Country Status (33)

Country Link
US (1) US6369108B1 (es)
EP (1) EP1051172B1 (es)
JP (1) JP2003522095A (es)
KR (1) KR100555824B1 (es)
CN (1) CN1291891A (es)
AP (1) AP2000001859A0 (es)
AR (1) AR014411A1 (es)
AT (1) ATE285234T1 (es)
AU (1) AU752497B2 (es)
BG (1) BG104654A (es)
BR (1) BR9906803A (es)
CA (1) CA2317720A1 (es)
DE (1) DE69922786T2 (es)
DZ (1) DZ2703A1 (es)
EA (1) EA006382B1 (es)
EG (1) EG23945A (es)
ES (1) ES2234234T3 (es)
HU (1) HUP0100888A3 (es)
ID (1) ID26164A (es)
IL (1) IL137104A0 (es)
MA (1) MA26592A1 (es)
MY (1) MY133014A (es)
NO (1) NO20003481L (es)
NZ (1) NZ505521A (es)
OA (1) OA11443A (es)
PE (1) PE20000231A1 (es)
PL (1) PL341667A1 (es)
PT (1) PT1051172E (es)
SI (1) SI1051172T1 (es)
SK (1) SK285149B6 (es)
TR (1) TR200001819T2 (es)
UY (1) UY25338A1 (es)
WO (1) WO1999034798A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
AR024076A1 (es) * 1999-05-25 2002-09-04 Smithkline Beecham Corp Sales de cis-[4-ciano-4-(3-ciclopentiloxi-4-metoxifenil) ciclohexan-1-carboxilato]
CO5190716A1 (es) * 1999-08-10 2002-08-29 Smithkline Beecham Corp 4,4-diaril-ciclohexanos 1,4-sustituidos
EP1237851A4 (en) * 1999-12-15 2004-06-23 Smithkline Beecham SALES OF I CIS / I-4-CYANO-4-3- (CYCLOPENTYLOXY) -4-METHOXYPHENYL] CYCLHEXAN-1-CARBONIC ACID
WO2001068600A2 (en) 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Limited Benzylated pde4 inhibitors
DE10245153A1 (de) * 2002-09-27 2004-04-15 Infineon Technologies Ag Integrierter Feldeffekttransistor mit zwei Steuerbereichen, Verwendung dieses Feldeffekttranistors und Herstellungsverfahren
ES2382876T3 (es) 2005-05-31 2012-06-14 Pfizer, Inc. Compuestos de ariloxi-N-biciclometil-acetamida sustituidos como antagonistas de VR1
CN101679191B (zh) 2007-06-05 2014-03-12 塞诺菲-安万特股份有限公司 二杂芳基环己烷衍生物、其制备方法、用途及含有它们的药用组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633776B1 (en) * 1992-04-02 2001-05-09 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
EP0633771A4 (en) * 1992-04-02 1995-02-22 Smithkline Beecham Corporation Compounds.
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas

Also Published As

Publication number Publication date
KR100555824B1 (ko) 2006-03-03
EA006382B1 (ru) 2005-12-29
AP2000001859A0 (en) 2000-09-30
TR200001819T2 (tr) 2000-11-21
CN1291891A (zh) 2001-04-18
EP1051172B1 (en) 2004-12-22
KR20010033909A (ko) 2001-04-25
DZ2703A1 (fr) 2003-09-01
ES2234234T3 (es) 2005-06-16
HK1033551A1 (en) 2001-09-07
SK285149B6 (sk) 2006-07-07
NO20003481L (no) 2000-08-25
ID26164A (id) 2000-11-30
EP1051172A2 (en) 2000-11-15
MA26592A1 (fr) 2004-12-20
AR014411A1 (es) 2001-02-28
MY133014A (en) 2007-10-31
BG104654A (en) 2001-04-30
UY25338A1 (es) 2001-08-27
JP2003522095A (ja) 2003-07-22
DE69922786D1 (de) 2005-01-27
AU2106099A (en) 1999-07-26
PL341667A1 (en) 2001-04-23
OA11443A (en) 2004-04-28
SI1051172T1 (en) 2005-06-30
NZ505521A (en) 2004-02-27
SK10232000A3 (sk) 2001-01-18
HUP0100888A2 (hu) 2001-08-28
CA2317720A1 (en) 1999-07-15
AU752497B2 (en) 2002-09-19
ATE285234T1 (de) 2005-01-15
DE69922786T2 (de) 2005-06-23
IL137104A0 (en) 2001-06-14
EP1051172A4 (en) 2002-08-14
EA200000740A1 (ru) 2001-02-26
WO1999034798A1 (en) 1999-07-15
NO20003481D0 (no) 2000-07-06
US6369108B1 (en) 2002-04-09
EG23945A (en) 2008-01-22
HUP0100888A3 (en) 2003-07-28
PT1051172E (pt) 2005-03-31
BR9906803A (pt) 2002-05-28

Similar Documents

Publication Publication Date Title
PE20000231A1 (es) Metodo para tratar copd (enfermedad pulmonar obstructiva cronica)
AR035522A1 (es) Compuestos derivados de fenol, composiciones farmaceuticas, su uso y metodo de tratamiento
GB1493961A (en) Aryloxyphenylpropylamines
EA200000468A1 (ru) Терапевтическая композиция для введения толтеродина с контролируемым высвобождением
PE10399A1 (es) Derivados de aminoacidos
EA200700232A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
PT87163A (pt) Process for preparing 1-phenyl-3-naphthalenyloxipropanamines
KR880006247A (ko) 티에노피리디논 및 이의 제조방법
AU8902591A (en) Substituted imidazobenzazepines and imidazopyridoazepines
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
ES2185153T3 (es) Uso de mefloquina(+) para el tratamiento de la malaria.
RU2003118131A (ru) Способ лечения ран
PE20011044A1 (es) Derivados de aminometil-fenil-ciclohexano sustituidos, procedimiento para su preparacion y medicamentos que contienen estos compuestos
AR044869A1 (es) Compuesto de dicetopiperazina, composicion farmaceutica que lo comprende, su uso para fabricar un medicamento y procedimiento para su preparacion
Gruhzit et al. A pharmacologic study of certain thiobarbiturates
DE3785225D1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
ES8401948A1 (es) Un procedimiento de preparacion de 1-(1-bencimidazolil)-3-n-2-(4-hidroxi-3-metoxifenil)-2-hidroxietil amino-butano.
CO5271703A1 (es) Compuestos quimicos
PT900082E (pt) Utilizacao de piridilpiperazina e pirimidilpiperazina para o fabrico de um medicamento para o tratamento de perturbacoes de toxicomania
ATE336487T1 (de) Benzoesaüre derivate und deren verwendung
CA2050875A1 (en) 3-(1h-indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments
KR950701518A (ko) 알쯔하이머 질환의 치료에 있어서 (E)-2-(p-플로오로펜에틸)-3-플루오로알릴아민의 용도(Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatmet of Alzheimer's disease)
CO5170530A1 (es) Procedimietno para preparar derivados de 10,11-metanobenzosuberano
EP0116255A3 (en) Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives

Legal Events

Date Code Title Description
FC Refusal